ID: ALA3276816

Max Phase: Preclinical

Molecular Formula: C21H27N3O

Molecular Weight: 337.47

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCN(CC)CCN1CCN(c2ccccc2)c2ccccc2C1=O

Standard InChI:  InChI=1S/C21H27N3O/c1-3-22(4-2)14-15-23-16-17-24(18-10-6-5-7-11-18)20-13-9-8-12-19(20)21(23)25/h5-13H,3-4,14-17H2,1-2H3

Standard InChI Key:  DUKOQRXNBYNJED-UHFFFAOYSA-N

Associated Targets(non-human)

Mus musculus 284745 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Ileum 856 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 337.47Molecular Weight (Monoisotopic): 337.2154AlogP: 3.62#Rotatable Bonds: 6
Polar Surface Area: 26.79Molecular Species: BASEHBA: 3HBD: 0
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.01CX LogP: 3.50CX LogD: 1.88
Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.81Np Likeness Score: -1.16

References

1. Bagolini C, de Witt P, Pacifici L, Ramacci MT..  (1978)  Synthesis and pharmacological activity and some derivatives of 1-phenyl-1,2,3,4-tetrahydro-5H-1,4-benzodiazepin-5-one.,  21  (5): [PMID:26804] [10.1021/jm00203a015]

Source